Can cirrhosis make colon polyp removal riskier? a study digs into bleeding rates.
NCT ID NCT06832826
First seen Sep 04, 2026 · Last updated Sep 04, 2026
Summary
Researchers are reviewing records from 60 people with liver cirrhosis and portal hypertension who had colon polyps removed during a colonoscopy. The goal is to see whether bleeding right after the procedure or in the following days happens more often in this group. The study also looks at the types of polyps found. The findings could help doctors weigh the risks before removing polyps in patients with advanced liver disease.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Colonoscopy polypectomy (removal of colon polyps during a scope procedure)
- What this could lead to
- If bleeding risks are better understood, doctors could tailor how they remove colon polyps in people with cirrhosis, potentially reducing complications.
- What could go wrong
- This is a small, single-center review of past cases, so its findings may not apply broadly. It does not test a new treatment, and bleeding risk depends on many individual factors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
60 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
Mar 2025
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Liver cirrhosis patients with evidence of portal hypertension
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All liver cirrhosis patients with portal hypertension and colonic polyps Exclusion Criteria: * Patients with platelet count less than 50,000/µL. * Patients with hemoglobin levels less than 8 g/dL. * Prothrombin Time more than 20 seconds.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Liver cirrhosis are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zagazig University Hospital
Zagazig, Sharqia Province, 44519, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a parasite drug help fight a deadly gut infection in cirrhosis?
- Can an antioxidant boost the Body's fight against a deadly infection in cirrhosis?
- Can a smaller stent tame brain fog after liver shunt surgery?
- Thyroid trouble may worsen liver scarring in fatty liver disease
- Could smarter scores save lives on the liver transplant waitlist?
- Can a simple pill or a glue injection stop deadly stomach bleeding?